Prognostic implication of PD-L1 expression and associated tumor infiltrating lymphocytes in metastatic breast cancer

Mohamed M Darwish ¹ , Atef Y Riad ¹, Dina A Salem ¹, Ahmad E Essa ¹, Marwa M Shakweer ² * , Diaa Eldin M. Sherif ¹

Cited by CrossRef: 8

1- Arabpour J, Rezaei K, Khojini J, Razi S, Hayati M, Gheibihayat S. The potential role and mechanism of circRNAs in Ferroptosis: A comprehensive review. Pathology - Research and Practice. 2024;255:155203 [Crossref]

2- Haghighi S, Ghaderian S, Rakhshan A, Motamed N. Evaluation of the Expression of miRNAs, LncRNAs, and their Target Gene, Caspase 3 in Glioblastoma Multiform: A Case–Control Study. Mol Biotechnol. 2023;65(9):1444 [Crossref]

3- Kardooni A, Bahrampour A, Golmohammadi S, Jalili A, Alishahi M. The Role of Epithelial Mesenchymal Transition (EMT) in Pathogenesis of Cardiotoxicity: Diagnostic & Prognostic Approach. Mol Biotechnol. 2023;65(9):1403 [Crossref]

4- Farghadani M, Mozafari S, Riahinejad M, Haghighi M, Samani R, Taravati A, Rostami K, Shahrokh S, Sadeghian A. Determining the Diagnostic Value of DWIBS in the Diagnosis of Breast Lesions Compared to Dynamic Contrast-Enhanced MRI: A Retrospective Observational Study. 2025;14(1) [Crossref]

5- Mondal S, Bhattacharya S, Sarkar A, Saha R. Expression of programmed death ligand-1 (PD-L1) and tumor infiltrating lymphocytes (TILs) in breast carcinoma and their clinical significance. 2023;19(Suppl 1):S81 [Crossref]

6- Ranapour S, Motamed N. Effect of Silibinin on the Expression of Mir-20b, Bcl2L11, and Erbb2 in Breast Cancer Cell Lines. Mol Biotechnol. 2023;65(12):1979 [Crossref]

7- Saastad S, Skjervold A, Ytterhus B, Engstrøm M, Bofin A. PD-L1 protein expression in breast cancer. J Clin Pathol. 2024;77(11):730 [Crossref]

8- Ghasemi Darestani N, Gilmanova A, Al-Gazally M, Zekiy A, Ansari M, Zabibah R, Jawad M, Al-Shalah S, Rizaev J, Alnassar Y, Mohammed N, Mustafa Y, Darvishi M, Akhavan-Sigari R. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment. Cell Commun Signal. 2023;21(1) [Crossref]

9- Bao S, Darvishi M, H Amin A, Al-Haideri M, Patra I, Kashikova K, Ahmad I, Alsaikhan F, Al-qaim Z, Al-Gazally M, Kiasari B, Tavakoli-Far B, Sidikov A, Mustafa Y, Akhavan-Sigari R. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment. J Cancer Res Clin Oncol. 2023;149(10):7945 [Crossref]

10- Yang M, Zhang Y, Li M, Liu X, Darvishi M. The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies. Cancer Cell Int. 2023;23(1) [Crossref]